Part-IIIAdvances Dihydropyridines and …154. Baker, D. J.; Jeganathan, K. B.; Cameron, J. D.; Thompson, M.; Juneja, S.;Kopecka, A.; Kumar, R.; Jenkins, R. B.; Groen, P. C.; Roche, P.; Deursen, J. M.Nat. Genet 2004, 36, 744.155. Cahill, D. P.; Lengauer, C.; Yu. J.; Riggins, G. J.; Willson, J. K. V.; Markowitz, S.D.; Kinzler, K. W.; Vogelstein, B. Nature 1998, 392, 300.156. Dai, W.; Wang, Q.; Liu, T.; Swamy, M.; Fang, Y.; Xie, S.; Mahmood, R.; Yang,Y.-M.; Xu, M.; Rao, C.V. Cancer Res, 2004, 64, 440.157. Hanks, S.; Coleman, K.; Reid, S.; Plaja, A.; Firth, H.; FitzPatrick, D.; Kidd, A.;Mehes, K.; Nash, R.; Robin, N.; Shannon, N.; Tolmie, J.; Swansbury, J.; Irrthum,A.; Douglas, J.; Rahman, N. Nat. Genet. 2004, 36, 1159.158. Michel, L.; Diaz-Rodriguez, E.; Narayan, G.; Hernando, E.; Murty, V. V.;Benezra, R. Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 4459.159. Saeki, A.; Tamura, S.; Ito, N.; Kiso, S.; Matsuda,Y.; Yabuuchi, I.; Kawata, S.;Matsuzawa, Y. Cancer 2002, 94, 2047.160. Shin, H.-J.; Baek, K.-H.; Jeon, A.-H.; Park, M.-T.; Lee, S.-J.; Kang, C.-M.; Lee,H.-S.; Yoo, S.-H.; Chung, D.-H.; Sung, Y.-C.; McKeon, F.; Lee, C.-W. CancerCell 2003, 4, 483.161. Kasai, T.; Iwanaga, Y.; Iha, H.; Jeang, K. T. J. Biol. Chem. 2002, 277, 5187.162. Sudo, T.; Nitta, M.; Saya, H.; Ueno, N. T. Cancer Res. 2004, 64, 2502.163. Masuda, A.; Maeno, K.; Nakagawa, T.; Saito, H.; Takahashi, T. Am. J. Pathol.2003, 163, 1109.164. Lee, E. A.; Keutmann, M. K.; Dowling, M. L.; Harris, E.; Chan, G.; Kao, G. D.Mol. Cancer Ther. 2004, 3, 661.165. Sihn, C. R.; Suh, E. J.; Lee, K. H.; Kim, T. Y.; Kim, S. H. Cancer Lett. 2003, 201,203.166. Tao, W.; South, V. J.; Zhang, Y.; Davide, J. P.; Farrell, L.; Kohl, N. E.; Sepp-Lorenzino, L.; Lobell, R. B. Cancer Cell 2005, 8, 49.167. Chin, G. M.; Herbst, R. Mol. Cancer Ther. 2006, 5, 2580.168. Kappe, C. O. Acc. Chem. Res. 2000, 33, 879.169. Kappe, C. O. Eur. J. Med. Chem. 2000, 35, 1043.170. Kappe, C. O. Molecules 1998, 3, 1.171. Jauk, B. ; Pernat, T. ; Kappe, C. O. Molecules 2000, 5, 227.448
Part-IIIAdvances Dihydropyridines and …172. Patil, A. D.; Kumar, N. V.; Kokke, W. C.; Bean, M. F.; Freyer, A. J.; Brosse, C.D.; Mai, S.; Truneh, A.; Faulkner, D. J.; Carte, B.; Breen, A. L.; Hertzberg, R. P.;Johnson, R. K.; Westley, J. W. ; Potts, B. C. M. J. Org. Chem. 1995, 60, 1182.173. Mayer, T. U.; Kapoor, T. M.; Haggarty, S. J.; King, R. W.; Schreiber, S. I.;Mitchison, T. J. Science 1999, 268, 971.174. Cochran, J. C.; Gatial, J. E.; Kapoor, T. M.; Gilbert, S. P. J. Biol. Chem. 2005,280, 12658.175. Sakowicz, R.; Finer, J. T.; Beraud, C.; Crompton, A.; Lewis, E.; Fritsch, A.; Lee,Y.; Mak, J.; Moody, R.; Turincio, R.; Chabal, J. C.; Gonzales, P.; Roth, S.;Weitman, S.; Wood, K. W. Cancer Res. 2004, 64, 3276.176. Brier, S.; Lemaire, D.; DeBonis, S.; Forest, E.; Kozielski, F. Biochemistry 2004,43, 13072.177. Heald, R. Cell 2000, 102, 399.178. Peters, T.; Lindenmaier, H.; Haefeli, W. E.; Weiss, J. Arch. Pharmacol. 2006,372, 291.179. Maliga, Z.; Kapoor, T. M.; Mitchison, T. J. Chem. Biol. 2000, 9, 989.180. Kapoor, T. M.; Mayer, T. U.; Coughlin, M. L.; Mitchison, T. J. J. Cell Biol. 2000,150, 975.181. DeBonis, S.; Simorre, J-P.; Crevel, I.; Lebeau, L.; Skoufias, D. A.; Blangy, A.;Ebel, C.; Gans, P.; Cross, R.; Hackney, D. D.; Wade, R. H.; Kozielski, F.Biochemistry 2003, 42, 338.182. Cochran, J. C.; Gilbert, S. P. Biochemistry 2005, 44, 16633.183. Bokaeva, S. S. Tr. Kaz. Nauch.-lssled. Inst.-Onkol. Radiol. 1967, 3, 305. [Chem.Abstr. 68 (1968) 103775q].184. Duburs, Z. G.; Zilbere, A.; Verpele, R.; Uldrikis, J.; Kumsars, K. Latv. PSR Zinat.Akad. Vestis. 1971, 77. [Chem. Abstr. 75 (1971) 47266e].185. Kumsars, K.; Velena, A.; Duburs, G.; Uldrikis, J.; Zidermane, A. Biokhimiya1971, 36, 1201.186. Kato, T. Japn. Kokai Tokkyo Koho JP 59190974, 1984. [Chem. Abstr. 102 (1985)132067].187. Leizerman, R.; Avunie-Masala, M.; Elkabets, M.; Fich, A.; Gheber, L. Cell. Mol.Life Sci. 2004, 61, 2060.449
- Page 1 and 2:
Saurashtra UniversityRe - Accredite
- Page 3 and 4:
Statement Under O.Ph.D. 7 of Sauras
- Page 5 and 6:
ContentsAcknowledgementRegistration
- Page 7 and 8:
Contents1.2 Synthesis of condensed
- Page 9 and 10:
Contents1.5 MDR modulators 3981.6 D
- Page 11 and 12:
infrastructure and all the faciliti
- Page 13 and 14:
Above all I thank Lord Hanuman Ji a
- Page 15 and 16:
Abbreviations used1 H NMR Proton Nu
- Page 17 and 18:
UVVEGFRWCRWHOZ-EUltra VioletVascula
- Page 19 and 20:
22. 2-Substitutedthieno[3,2-d]/benz
- Page 21 and 22:
PrefacePrefaceHeterocyclic chemistr
- Page 23 and 24:
PrefaceThis entire cascade of react
- Page 25 and 26:
PrefaceOONHNHPOCl 3MWINVi-xviiClClC
- Page 27 and 28:
PrefaceOOHOOOONHNHDP-7 1NHMonastrol
- Page 29 and 30:
PART-I
- Page 31 and 32:
3.7 Results and discussion on biolo
- Page 33 and 34:
Part-1Review on Antiulcer Literatur
- Page 35 and 36:
Part-1Review on Antiulcer Literatur
- Page 37 and 38:
Table 2: Distinguishing Features of
- Page 39 and 40:
Part-1Review on Antiulcer Literatur
- Page 41 and 42:
1.2.2. Muscarinic AntagonistsPart-1
- Page 43 and 44:
Part-1Review on Antiulcer Literatur
- Page 45 and 46:
Part-1Review on Antiulcer Literatur
- Page 47 and 48:
Part-1Review on Antiulcer Literatur
- Page 49 and 50:
Part-1Review on Antiulcer Literatur
- Page 51 and 52:
Part-1Review on Antiulcer Literatur
- Page 53 and 54:
Part-1Review on Antiulcer Literatur
- Page 55 and 56:
1.5.5. Pharmacological PropertiesPa
- Page 57 and 58:
Part-1Review on Antiulcer Literatur
- Page 59 and 60:
Part-1Review on Antiulcer Literatur
- Page 61 and 62:
Part-1Review on Antiulcer Literatur
- Page 63 and 64:
Part-1Review on Antiulcer Literatur
- Page 65 and 66:
Part-1Review on Antiulcer Literatur
- Page 67 and 68:
Part-1Review on Antiulcer Literatur
- Page 69 and 70:
Part-1Review on Antiulcer Literatur
- Page 71 and 72:
Part-1Review on Antiulcer Literatur
- Page 73 and 74:
Part-1Review on Antiulcer Literatur
- Page 75 and 76:
Part-1Review on Antiulcer Literatur
- Page 77 and 78:
Part-1Review on Antiulcer Literatur
- Page 79 and 80:
Part-1Review on Antiulcer Literatur
- Page 81 and 82:
Part-1Review on Antiulcer Literatur
- Page 83 and 84:
Part-1Review on Antiulcer Literatur
- Page 85 and 86:
Part-1Review on Antiulcer Literatur
- Page 87 and 88:
Part-1Review on Antiulcer Literatur
- Page 89 and 90:
2. Aim of the Present WorkPart-IAim
- Page 91 and 92:
Part-IAim of Present WorkR 2 OR 3 R
- Page 93 and 94:
2.2. Bacisity of Pyridine vs Pyrimi
- Page 95 and 96:
Part-IAim of Present WorkOANNHOSNHN
- Page 97 and 98:
Part-IAim of Present WorkS. No. A S
- Page 99 and 100:
3. Results and Discussion
- Page 101 and 102:
Part-IResults and Discussion3.1.1d
- Page 103 and 104:
Part-IResults and DiscussionOR 1XR
- Page 105 and 106:
Part-IResults and Discussionformed
- Page 107 and 108:
Part-IResults and DiscussionOOON 2
- Page 109 and 110:
c. Synthesis of 2-carbethoxy-3-amin
- Page 111 and 112:
Part-IResults and DiscussionTable 7
- Page 113 and 114:
Part-IResults and DiscussionOOEtNHO
- Page 115 and 116:
Part-IResults and DiscussionTable-8
- Page 117 and 118:
Part-IResults and DiscussionCompd.N
- Page 119 and 120:
Part-IResults and DiscussionStep-IY
- Page 121 and 122:
S. No. Y Mol. Formula(Sol. ofrecrys
- Page 123 and 124:
Part-IResults and DiscussionS. No.
- Page 125 and 126:
Part-IResults and DiscussionS. No.
- Page 127 and 128:
Part-IResults and DiscussionONNHIII
- Page 129 and 130:
Part-IResults and DiscussionS. No.A
- Page 131 and 132:
Part-IResults and DiscussionS. No.A
- Page 133 and 134:
Part-IResults and DiscussionS. No.A
- Page 135 and 136:
Part-IResults and Discussion3.5. Sp
- Page 137 and 138:
Specimen 1 H NMR spectra of 2-chlor
- Page 139 and 140:
Part-IResults and Discussioninvolve
- Page 141 and 142:
Part-IResults and DiscussionSpecime
- Page 143 and 144:
The Infrared (IR) spectra:Part-IRes
- Page 145 and 146:
Part-IResults and DiscussionR 1ON+
- Page 147 and 148:
Part-IResults and DiscussionOSNHOSN
- Page 149 and 150:
3.6 Biological Evaluation of PPI’
- Page 151 and 152:
Part-IResults and DiscussionExperim
- Page 153 and 154:
Part-IResults and DiscussionDrug Pr
- Page 155 and 156:
Table 11. Effect of newly synthesiz
- Page 157 and 158:
Part-IResults and DiscussionS.No.AR
- Page 159 and 160:
Part-IResults and DiscussionS.No.AR
- Page 161 and 162:
Figure-1. Effect of newly synthesiz
- Page 163 and 164:
Figure-3. Effect of newly synthesiz
- Page 165 and 166:
Part-IResults and DiscussionFigure
- Page 167 and 168:
Part-IResults and DiscussionFigure
- Page 169 and 170:
Part-IResults and Discussion2. Effe
- Page 171 and 172:
Part-IResults and Discussionby kine
- Page 173 and 174:
Part-IResults and DiscussionNNNNNHN
- Page 175 and 176:
3.8. QSAR StudiesPart-IResults and
- Page 177 and 178:
Part-IResults and DiscussionFigure-
- Page 179 and 180:
Part-IResults and DiscussionPhysico
- Page 181 and 182:
Part-IResults and DiscussionS. No.
- Page 183 and 184:
Part-IResults and DiscussionThe MDS
- Page 185 and 186:
2. Volume of gastric secretion:Desc
- Page 187 and 188:
Part-IResults and DiscussionFor the
- Page 189 and 190:
Part-IResults and DiscussionTable-1
- Page 191 and 192:
3. Ulcer scoreDescription of the de
- Page 193 and 194:
Part-IResults and DiscussionTable-1
- Page 195 and 196:
Part-IResults and DiscussionTable-1
- Page 197 and 198:
Part-IResults and Discussion24. Ros
- Page 199 and 200:
4. Experimental
- Page 201 and 202:
Part-IExperimental119 o C was 128-1
- Page 203 and 204:
5. Synthesis of ethyl 2-amino-4-phe
- Page 205 and 206:
Part-IExperimentalthe procedure des
- Page 207 and 208:
Part-IExperimentalRecrystallization
- Page 209 and 210:
Part-IExperimentalM.P. : 132-134 o
- Page 211 and 212:
Part-IExperimentalA solution of thi
- Page 213 and 214:
Part-IExperimentalNMR (CDCl 3 )δpp
- Page 215 and 216:
Part-IExperimental6. Reaction of et
- Page 217 and 218:
Part-IExperimentalNMR (CDCl 3 )δpp
- Page 219 and 220:
Part-IExperimentalM.P. : 240-245 o
- Page 221 and 222:
Part-IExperimentalrecrystallization
- Page 223 and 224:
Part-IExperimental(1H, d, CH at imi
- Page 225 and 226:
Part-IExperimentalNMR (DMSO-d 6 )δ
- Page 227 and 228:
M.P. : 140-142 o C; Yield: 73%.Mol.
- Page 229 and 230:
M.P. : 135-141 o C; Yield: 67%.Mol.
- Page 231 and 232:
Part-IExperimentalml), over a perio
- Page 233 and 234:
Part-IExperimentalchloride was adde
- Page 235 and 236:
Part-IExperimental29. Synthesis of
- Page 237 and 238:
Part-IExperimentalIR (KBr) cm -1 :
- Page 239 and 240:
Part-IExperimentaladded while stirr
- Page 241 and 242:
Part-IExperimentald]pyrimidin-4(3H)
- Page 243 and 244:
Part-IExperimentalMol. formula : C
- Page 245 and 246:
Part-IExperimentalthis clear soluti
- Page 247 and 248:
Part-IExperimental21. Synthesis of
- Page 249 and 250:
Part-IExperimentalwhile maintaining
- Page 251 and 252:
Part-IExperimental30. Synthesis of
- Page 253 and 254:
Part-IExperimentalMol. Formula : C
- Page 255 and 256:
PART-II
- Page 257 and 258:
Part-IIContents2.3.2.1 Mononuclear
- Page 259 and 260:
Part-IISynthesis of Pyrimidines1. S
- Page 261 and 262:
Part-IISynthesis of PyrimidinesYZR
- Page 263 and 264:
Part-IISynthesis of Pyrimidineselec
- Page 265 and 266:
Part-IISynthesis of PyrimidinesR 1R
- Page 267 and 268:
Part-IISynthesis of Pyrimidinespyri
- Page 269 and 270:
R 1 R 2 R Yield(%)Part-IISynthesis
- Page 271 and 272:
R 1 R 2 R Yield(%)Part-IISynthesis
- Page 273 and 274:
R 1 R 2 R Yield(%)Part-IISynthesis
- Page 275 and 276:
Part-IISynthesis of Pyrimidinesyiel
- Page 277 and 278:
Table 27: 2-Amino-3-substitutedaryl
- Page 279 and 280:
Part-IISynthesis of PyrimidinesWhil
- Page 281 and 282:
Part-IISynthesis of PyrimidinesSimi
- Page 283 and 284:
Part-IISynthesis of PyrimidinesTabl
- Page 285 and 286:
R 1 R 2 R X Yield(%)Part-IISynthesi
- Page 287 and 288:
Part-IISynthesis of Pyrimidines+RCN
- Page 289 and 290:
Part-IISynthesis of PyrimidinesNN+
- Page 291 and 292:
Part-IISynthesis of PyrimidinesR 1+
- Page 293 and 294:
Part-IISynthesis of Pyrimidinesthe
- Page 295 and 296:
Part-IISynthesis of Pyrimidinesacet
- Page 297 and 298:
Part-IISynthesis of Pyrimidinesexpe
- Page 299 and 300:
Part-IISynthesis of PyrimidinesNOOC
- Page 301 and 302:
Part-IISynthesis of PyrimidinesThe
- Page 303 and 304:
Part-IISynthesis of PyrimidinesTabl
- Page 305 and 306:
Part-IISynthesis of PyrimidinesOH 3
- Page 307 and 308:
1.10 ReferencesPart-IISynthesis of
- Page 309 and 310:
Part-IISynthesis of Pyrimidines42.
- Page 311 and 312:
2. Impact of Microwave Assisted Hea
- Page 313 and 314:
Part-IIImpact of Microwave…Microw
- Page 315 and 316:
Part-IIImpact of Microwave…Figure
- Page 317 and 318:
Part-IIImpact of Microwave…R 1ArR
- Page 319 and 320:
Part-IIImpact of Microwave…as an
- Page 321 and 322:
Part-IIImpact of Microwave…al. 21
- Page 323 and 324:
Part-IIImpact of Microwave…XOHR 1
- Page 325 and 326:
Part-IIImpact of Microwave…N+N21B
- Page 327 and 328:
Part-IIImpact of Microwave…OO+ NO
- Page 329 and 330:
Part-IIImpact of Microwave…NO 2NO
- Page 331 and 332:
Part-IIImpact of Microwave…RNHNNH
- Page 333 and 334:
Part-IIImpact of Microwave…assist
- Page 335 and 336:
Part-IIImpact of Microwave…CNRNH
- Page 337 and 338:
Part-IIImpact of Microwave…Multig
- Page 339 and 340:
Part-IIImpact of Microwave…Nie et
- Page 341 and 342:
Part-IIImpact of Microwave…synthe
- Page 343 and 344:
Part-IIImpact of Microwave…An eff
- Page 345 and 346:
Part-IIImpact of Microwave…OO+S 8
- Page 347 and 348:
2.6. ReferencesPart-IIImpact of Mic
- Page 349 and 350:
49. Baxendale, I. R.; Ley, S. V. J.
- Page 351 and 352:
Part-IIAim of the Present Work3. Ai
- Page 353 and 354:
Part-IIAim of the Present WorkONHR
- Page 355 and 356:
Part-IIAim of the Present WorkYZXNN
- Page 357 and 358:
Part-IIAim of the Present WorkThe c
- Page 359 and 360:
3.5 References:Part-IIAim of the Pr
- Page 361 and 362:
Part-IIAim of the Present Work37. S
- Page 363 and 364:
Part-IIResults and Discussion4.1 Sy
- Page 365 and 366:
4.2 Synthesis of condensed 2-substi
- Page 367 and 368:
Table 38: Physical data of condense
- Page 369 and 370:
S. No. X Time ofMWIHeating(Min)VxiV
- Page 371 and 372:
S. No. X Time ofMWIHeating(Min)Yiel
- Page 373 and 374:
4.3 Synthesis of condensed 4-chloro
- Page 375 and 376:
Part-IIResults and DiscussionHerein
- Page 377 and 378:
Part-IIResults and DiscussionS. No.
- Page 379 and 380:
Part-IIResults and DiscussionS. No.
- Page 381 and 382:
The Mass spectraPart-IIResults and
- Page 383 and 384:
Specimen IR spectra of some 2-chlor
- Page 385 and 386:
Specimen IR spectra of some 2-chlor
- Page 387 and 388:
Part-IIResults and Discussion1 H NM
- Page 389 and 390:
Part-IIResults and Discussionion (c
- Page 391 and 392:
Specimen IR spectra of some 4-chlor
- Page 393 and 394:
Specimen 1 H NMR spectra of 4-chlor
- Page 395 and 396:
Part-IIResults and Discussion4.5 MD
- Page 397 and 398:
Part-IIResults and DiscussionH 3CO1
- Page 399 and 400:
Part-IIResults and DiscussionCl14.
- Page 401 and 402:
Part-IIResults and DiscussionO14. V
- Page 403 and 404:
4.6 References:Part-IIResults and D
- Page 405 and 406:
5. ExperimentalPart-IIExperimentalA
- Page 407 and 408:
3. Synthesis of 2-chloromethyl-5-ph
- Page 409 and 410:
Part-IIExperimentalIR (KBr) cm -1 :
- Page 411 and 412:
Part-IIExperimentalM.P. : 247-249 o
- Page 413 and 414:
Part-IIExperimental5.4 Synthesis of
- Page 415 and 416:
Part-IIExperimentalwere reacted und
- Page 417 and 418:
27. Synthesis of 2-methyl-5-phenylt
- Page 419 and 420:
Part-IIExperimental80 o C) that yie
- Page 421 and 422:
Part-IIExperimental36. Synthesis of
- Page 423 and 424:
Part-IIExperimentalunder microwave
- Page 425 and 426:
Part-IIExperimentalM.P. : >300 o C
- Page 427 and 428:
M.P. : 280-282 o C; Yield: 90%Mol.
- Page 429 and 430:
5.10 References:Part-IIExperimental
- Page 431 and 432:
Synthesis, Characterization and Ant
- Page 433 and 434:
Part-IIIAdvances Dihydropyridines a
- Page 435 and 436:
Part-IIIAdvances Dihydropyridines a
- Page 437 and 438:
Part-IIIAdvances Dihydropyridines a
- Page 439 and 440:
Part-IIIAdvances Dihydropyridines a
- Page 441 and 442:
Part-IIIAdvances Dihydropyridines a
- Page 443 and 444: Part-IIIAdvances Dihydropyridines a
- Page 445 and 446: Part-IIIAdvances Dihydropyridines a
- Page 447 and 448: Part-IIIAdvances Dihydropyridines a
- Page 449 and 450: Part-IIIAdvances Dihydropyridines a
- Page 451 and 452: Part-IIIAdvances Dihydropyridines a
- Page 453 and 454: Part-IIIAdvances Dihydropyridines a
- Page 455 and 456: CH 3CH 3Part-IIIAdvances Dihydropyr
- Page 457 and 458: Part-IIIAdvances Dihydropyridines a
- Page 459 and 460: Part-IIIAdvances Dihydropyridines a
- Page 461 and 462: Part-IIIAdvances Dihydropyridines a
- Page 463 and 464: Part-IIIAdvances Dihydropyridines a
- Page 465 and 466: Part-IIIAdvances Dihydropyridines a
- Page 467 and 468: Part-IIIAdvances Dihydropyridines a
- Page 469 and 470: Part-IIIAdvances Dihydropyridines a
- Page 471 and 472: Part-IIIAdvances Dihydropyridines a
- Page 473 and 474: Part-IIIAdvances Dihydropyridines a
- Page 475 and 476: Part-IIIAdvances Dihydropyridines a
- Page 477 and 478: Part-IIIAdvances Dihydropyridines a
- Page 479 and 480: Part-IIIAdvances Dihydropyridines a
- Page 481 and 482: Part-IIIAdvances Dihydropyridines a
- Page 483 and 484: Part-IIIAdvances Dihydropyridines a
- Page 485 and 486: Part-IIIAdvances Dihydropyridines a
- Page 487 and 488: Part-IIIAdvances Dihydropyridines a
- Page 489 and 490: Part-IIIAdvances Dihydropyridines a
- Page 491 and 492: Part-IIIAdvances Dihydropyridines a
- Page 493: Part-IIIAdvances Dihydropyridines a
- Page 497 and 498: 2. Aim of the Present Work
- Page 499 and 500: Part-IIIAim of the Present Workshor
- Page 501 and 502: 3. Results and Discussion
- Page 503 and 504: Part-IIIResults and DiscussionOOOHR
- Page 505 and 506: Part-IIIResults and DiscussionUsing
- Page 507 and 508: Part-IIIResults and DiscussionS. No
- Page 509 and 510: S. No R X MolFormula(Sol. of Recrys
- Page 511 and 512: Part-IIIResults and Discussionpheny
- Page 513 and 514: Specimen 13 C NMR spectra of some D
- Page 515 and 516: Part-IIIResults and DiscussionTable
- Page 517 and 518: Part-IIIResults and DiscussionTable
- Page 519 and 520: 3.5 DiscussionPart-IIIResults and D
- Page 521 and 522: 4. Experimental
- Page 523 and 524: Part-IIIExperimentalglacial acetic
- Page 525 and 526: Part-IIIExperimental5. Synthesis of
- Page 527 and 528: Part-IIIExperimentalIR(KBr) cm -1 :
- Page 529 and 530: Part-IIIExperimentalM.P. : 184-186
- Page 531 and 532: Part-IIIExperimental1 H NMR(DMSO-d
- Page 533 and 534: Part-IIIExperimentalM.P. : 188-190
- Page 535 and 536: Part-IIIExperimental4.2 MDR reversa
- Page 537 and 538: Summary and Conclusion
- Page 539 and 540: Summary and Conclusionactivity in P
- Page 541 and 542: Summary and Conclusionreverting act
- Page 543 and 544: Publications and Presentations
- Page 545 and 546:
Publications and PresentationsOther
- Page 547:
Publications and Presentations8. K.